In addition to these tethering proteins, there are some proteins that do not directly participate in the structural maintenance of MAMs. However, these proteins do affect the structure of MAMs via protein–protein interactions (). In addition to being present in the cytoplasm, α-Synuclein can also be incorporated in MAMs [
57]. α-Synuclein can promote the Ca
2+ transfer from ER to mitochondria by increasing the ER and mitochondria contacts; and further study showed that the C-terminal of α-Synuclein is essential to tighten the contacts [
58]. Some studies revealed that the α-Synuclein existing in MAMs results in the dis-regulation of Ca
2+ and lipid metabolism, which promotes substantia nigra pars compacta neurons to die, leading to the progression of PD [
59]. In addition to playing an anti-apoptotic role in cells and participating in mitochondrial dynamics, DJ-1 can still exist in the MAMs, thus enhancing the connection between the ER and the mitochondria and the crosstalk between the two organelles; this effect may be related to P53 to some extent (an antagonistic relationship) [
60]. Existing studies suggest that DJ-1 can bind directly to the IP3R-Grp75-VDAC complex and affect its stability. The knockout of DJ-1 resulted in the aggregation of IP3R3 in MAMs and a reduction in the formation of the IP3Rs-Grp75-VDACs complex; it is possible that this is related to the pathophysiological process of obesity [
61]. Although the precise mechanism remains obscure, it has been ascertained that DJ-1 can affect the structural stability of MAMs. This also implies that MAMs may play a role in the pathogenesis of Parkinson’s syndrome. TDP-43 and FUS are proteins that are related to ALS/FTD and can activate GSK-3b by down-regulating the phosphorylation levels of serine 9 by GSK-3b. Once activated, GSK-3b can reduce the connections between VABP and PTPIP51, thereby detaching the ER from the mitochondria [
47,
62]. PDK4 can directly interact with the IP3Rs-Grp75-VDACs complex in MAMs and may promote the formation of this complex by regulating phosphorylation, thus increasing the area of contacts between the ER and the mitochondria [
42]. In addition to participating in the post-transcriptional modification of proteins, TG2 can also be incorporated in MAMs and act directly on Grp75 to increase the number of ER-mitochondrial contacts and thus participate in the structural maintenance of MAMs [
63]. The precise function of TpMs (a type of keratin binding protein that is partly located in the mitochondria) remains unclear although data indicates that this protein can negatively regulate the ER-mitochondria connections in a Mfn2-dependent manner [
64]. It is generally believed that CypD, a protein located in the mitochondrial matrix, can also be incorporated in MAMs, and directly act with the IP3Rs-Grp75-VDACs complex to regulate the stability of this complex. Inhibiting the function of CypD can down-regulate the binding of Grp75 with IP3Rs and VDACs, affecting the transfer of Ca
2+ between the two organelles [
65]. FUNDC1 is known for maintaining the stability of IP3R2 in MAMs by direct binding, and it enhances the level of contacts and the communication of Ca
2+ between the ER and the mitochondria [
66]. Presenilin-2 can also promote the connection and the transfer of Ca
2+ signals between the ER and the mitochondria in the presence of Mfn-2; these findings were confirmed by overexpression and knockdown experiments, which suggested that presenilin-2 works with the Mfn1/Mfn2 complex [
67]. FATE1 can reduce the level of contacts between the ER and the mitochondria and downregulate the transfer of Ca
2+ with an impaired sensitivity to Ca
2+-related apoptosis [
68]. In addition to participating in the morphological regulation of ER, NogoB can increase the gap width of MAMs and affect their function [
69]. PERK, which plays an important role in ERS, can increase the level of connectivity between the ER and the mitochondria by interacting with Mfn2, and thus promote the transduction of ERS signals to the mitochondria [
70,
71]. Although these proteins are not considered to be directly involved in maintaining the structure of MAMs, they still attract research attention due to their specific regulatory effects on the structure of MAMs and their involvement in the pathological processes underlying many neurodegenerative diseases.